Drugs treat people regardless of where they come from. But companies cannot just go out and simply offer the treatment with the same marketing strategy country by country. Companies often adapt their product name/logo to suit the cultural and language differences that exist in our global economy....case in point -- Coca Cola. The same is true for drug products, like that of Lupron.
Let's take a look at the variation in names and who sells the product in some countries:
Country | Product Name | Marketing Company |
Argentina, Brazil, Canada, Chile, United States, Venezuela | Lupron | Abbott |
Australia, Belgium, Czech Republic, France, Hungary, Israel, Malaysia, Mexico, Netherlands, New Zealand, Portugal, Russia, South Africa, Singapore, Switzerland, Turkey | Lucrin | Abbott |
Austria | Enantone, Trenantone | Takeda |
Denmark, Finland, Norway, Sweden | Enanton Procren | Orion Abbott |
Germany | Enantone-Gyn, Enantone Leupro-Sandoz Leuprone | Takeda Sandoz Hexal |
Greece | Daronda | Abbott |
Hong Kong, Thailand, Italy, | Enantone | Takeda |
India | Lupride | Sun Pharma |
Indonesia | Tapros Lectrum | Takeda Sandoz |
Ireland, United Kingdom | Prostap | Takeda |
Japan | Leuplin | Takeda |
Philippines | Luprolex Lucrin Depot | Takeda Abbott |
Spain | Procrin | Abbott |
S. Korea | Luphere Depot | Daewoong Pharmaceuticals |
The variations are very similar and there is no real definition of these words. So why do they need to change the names depending on the country? We can't find the direct reason. It's not like Lupron is an offensive word in any of these countries. So I pose this question to the world. Why is this done?
One possible explanation for the use of different product names in different countries is phonetics. Maybe Pfizer found more effective to use a different name for Lutron for phonetic reasons.
ReplyDeleteProfessor Robles
One possibility could be that all the countries have naming restrictions on drug names, therefore it may not so easy to pick a name for a medicine. Another possibility could be that if in the past a drug name was banned from the market, the drug companies usually make sure that a new drug will not sound similar to the banned name, as it might not be well perceived on the market and could have less potential for sales.
ReplyDeleteThose are some good points! We were having trouble with their naming strategies.
ReplyDeleteThank you Beth.
ReplyDelete